A detailed history of Csenge Advisory Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Csenge Advisory Group holds 2,994 shares of AZN stock, worth $225,208. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,994
Holding current value
$225,208
% of portfolio
0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$66.81 - $80.83 $200,029 - $242,005
2,994 New
2,994 $233,000
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $650 - $845
-12 Reduced 0.25%
4,720 $320,000
Q3 2022

Oct 04, 2022

SELL
$53.02 - $135.75 $55,299 - $141,587
-1,043 Reduced 18.06%
4,732 $260,000
Q2 2022

Jul 27, 2022

SELL
$59.26 - $71.14 $205,395 - $246,571
-3,466 Reduced 37.51%
5,775 $382,000
Q1 2022

May 09, 2022

SELL
$55.72 - $67.12 $22,120 - $26,646
-397 Reduced 4.12%
9,241 $613,000
Q4 2021

Feb 10, 2022

SELL
$54.02 - $63.83 $199,333 - $235,532
-3,690 Reduced 27.69%
9,638 $581,000
Q3 2021

Oct 20, 2021

BUY
$55.56 - $60.79 $205,016 - $224,315
3,690 Added 38.29%
13,328 $795,000
Q2 2021

Jul 21, 2021

BUY
$48.42 - $60.18 $242,487 - $301,381
5,008 Added 108.16%
9,638 $581,000
Q1 2021

Apr 28, 2021

SELL
$47.16 - $54.44 $8,866 - $10,234
-188 Reduced 3.9%
4,630 $231,000
Q4 2020

Jan 26, 2021

BUY
$48.52 - $58.02 $233,769 - $279,540
4,818 New
4,818 $241,000
Q4 2018

Feb 07, 2019

SELL
$36.86 - $41.49 $13,859 - $15,600
-376 Closed
0 $0
Q3 2018

Nov 19, 2018

BUY
$34.76 - $39.72 $13,069 - $14,934
376 New
376 $15,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.